Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+70.8%
5Y CAGR+18.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+70.8%/yr
vs -11.9%/yr prior
5Y CAGR
+18.0%/yr
Recent acceleration
Acceleration
+82.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$179.97M+66.5%
2024$108.10M+112.0%
2023$51.00M+41.2%
2022$36.12M+148.1%
2021$14.56M-81.5%
2020$78.70M-5.1%
2019$82.97M+38.4%
2018$59.96M+67.8%
2017$35.73M+285.5%
2016$9.27M-